DrugDomain - P11387

Gene name: TOP1
Protein name: DNA topoisomerase 1

List of molecules and drugs that target protein P11387

# DrugDomain Data DrugBank Accession Name Drug action Affinity data InChI Key SMILES

1 P11387_DB00762 DB00762 Irinotecan inhibitor
UWKQSNNFCGGAFS-XIFFEERXSA-N CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12

2 P11387_DB00970 DB00970 Dactinomycin inhibitor
RJURFGZVJUQBHK-IIXSONLDSA-N [H][C@@]12CCCN1C(=O)[C@H](NC(=O)[C@@H](NC(=O)C1=C3N=C4C(OC3=C(C)C=C1)=C(C)C(=O)C(N)=C4C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@]3([H])CCCN3C(=O)[C@H](NC1=O)C(C)C)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C2=O)C(C)C

3 P11387_DB00997 DB00997 Doxorubicin inhibitor IC50(nM) = 3200.0
AOJJSUZBOXZQNB-TZSSRYMLSA-N COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O

4 P11387_DB01030 DB01030 Topotecan inhibitor IC50(nM) = 21.0
Kd(nM) = 26.5
EC50(nM) = 54.0
UCFGDBYHRUNTLO-QHCPKHFHSA-N CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(C=CC(O)=C4CN(C)C)N=C13)C2=O

5 P11387_DB04690 DB04690 Camptothecin inhibitor IC50(nM) = 25.0
EC50(nM) = 350.0
VSJKWCGYPAHWDS-FQEVSTJZSA-N CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=CC=CC=C4N=C13)C2=O

6 P11387_DB04882 DB04882 Edotecarin n/a
QMVPQBFHUJZJCS-NTKFZFFISA-N OCC(CO)NN1C(=O)C2=C3C(NC4=C3C=CC(O)=C4)=C3N([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C4=C(C=CC(O)=C4)C3=C2C1=O

7 P11387_DB04967 DB04967 Lucanthone inhibitor
FBQPGGIHOFZRGH-UHFFFAOYSA-N CCN(CC)CCNC1=C2C(=O)C3=CC=CC=C3SC2=C(C)C=C1

8 P11387_DB05129 DB05129 Elsamitrucin n/a
MGQRRMONVLMKJL-KWJIQSIXSA-N CO[C@@H]1[C@@H](N)[C@@H](O[C@H]2[C@H](OC3=CC=CC4=C3C3=C5C(C(=O)OC6=C5C(=C(C)C=C6)C(=O)O3)=C4O)O[C@H](C)[C@H](O)[C@]2(C)O)O[C@H](C)[C@@H]1O

9 P11387_DB05482 DB05482 7-ethyl-10-hydroxycamptothecin n/a IC50(nM) = 1000.0
FJHBVJOVLFPMQE-QFIPXVFZSA-N CCC1=C2C=C(O)C=CC2=NC2=C1CN1C2=CC2=C(COC(=O)[C@]2(O)CC)C1=O

10 P11387_DB05630 DB05630 Sodium stibogluconate inhibitor
YQDGWZZYGYKDLR-UZVLBLASSA-K O.O.O.O.O.O.O.O.O.[Na+].[Na+].[Na+].[H][C@@]1(O[Sb]2(O)(O[Sb]34([O-])O[C@@H](C([O-])=O)[C@@]([H])(O3)[C@]([H])(O4)[C@H](O)CO)O[C@@H](C([O-])=O)[C@@]1([H])O2)[C@H](O)CO

11 P11387_DB05806 DB05806 Cositecan n/a
POADTFBBIXOWFJ-VWLOTQADSA-N CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C(CC[Si](C)(C)C)C4=CC=CC=C4N=C13)C2=O

12 P11387_DB06159 DB06159 Rubitecan n/a
VHXNKPBCCMUMSW-FQEVSTJZSA-N CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C1N=C1C=CC=C(C1=C3)[N+]([O-])=O)C2=O

13 P11387_DB07354 DB07354 2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM n/a
LXDREMZQGAILJU-UHFFFAOYSA-O COC1=C(OC)C=C2C3=C([NH+]=CC2=C1)C1=C(C3)C=C2OCOC2=C1

14 P11387_DB08159 DB08159 4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE n/a
AHIJTWCJGCWHMT-UHFFFAOYSA-N OC(=O)CCCN1C2=C(C(=O)C3=CC=CC=C23)C2=CC=CC=C2C1=O

15 P11387_DB11254 DB11254 Hexylresorcinol inhibitor
WFJIVOKAWHGMBH-UHFFFAOYSA-N CCCCCCC1=C(O)C=C(O)C=C1

#	DrugDomain Data	DrugBank Accession	Name	Drug action	Affinity data	InChI Key	SMILES
1	P11387_DB00762	DB00762	Irinotecan	inhibitor		UWKQSNNFCGGAFS-XIFFEERXSA-N	CCC1=C2CN3C(=CC4=C(COC(=O)[C@]4(O)CC)C3=O)C2=NC2=CC=C(OC(=O)N3CCC(CC3)N3CCCCC3)C=C12
2	P11387_DB00970	DB00970	Dactinomycin	inhibitor		RJURFGZVJUQBHK-IIXSONLDSA-N	[H][C@@]12CCCN1C(=O)[C@H](NC(=O)[C@@H](NC(=O)C1=C3N=C4C(OC3=C(C)C=C1)=C(C)C(=O)C(N)=C4C(=O)N[C@H]1[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C(=O)[C@]3([H])CCCN3C(=O)[C@H](NC1=O)C(C)C)[C@@H](C)OC(=O)[C@H](C(C)C)N(C)C(=O)CN(C)C2=O)C(C)C
3	P11387_DB00997	DB00997	Doxorubicin	inhibitor	IC50(nM) = 3200.0	AOJJSUZBOXZQNB-TZSSRYMLSA-N	COC1=CC=CC2=C1C(=O)C1=C(O)C3=C(C[C@](O)(C[C@@H]3O[C@H]3C[C@H](N)[C@H](O)[C@H](C)O3)C(=O)CO)C(O)=C1C2=O
4	P11387_DB01030	DB01030	Topotecan	inhibitor	IC50(nM) = 21.0 Kd(nM) = 26.5 EC50(nM) = 54.0	UCFGDBYHRUNTLO-QHCPKHFHSA-N	CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=C(C=CC(O)=C4CN(C)C)N=C13)C2=O
5	P11387_DB04690	DB04690	Camptothecin	inhibitor	IC50(nM) = 25.0 EC50(nM) = 350.0	VSJKWCGYPAHWDS-FQEVSTJZSA-N	CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=CC4=CC=CC=C4N=C13)C2=O
6	P11387_DB04882	DB04882	Edotecarin	n/a		QMVPQBFHUJZJCS-NTKFZFFISA-N	OCC(CO)NN1C(=O)C2=C3C(NC4=C3C=CC(O)=C4)=C3N([C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)C4=C(C=CC(O)=C4)C3=C2C1=O
7	P11387_DB04967	DB04967	Lucanthone	inhibitor		FBQPGGIHOFZRGH-UHFFFAOYSA-N	CCN(CC)CCNC1=C2C(=O)C3=CC=CC=C3SC2=C(C)C=C1
8	P11387_DB05129	DB05129	Elsamitrucin	n/a		MGQRRMONVLMKJL-KWJIQSIXSA-N	CO[C@@H]1[C@@H](N)[C@@H](O[C@H]2[C@H](OC3=CC=CC4=C3C3=C5C(C(=O)OC6=C5C(=C(C)C=C6)C(=O)O3)=C4O)O[C@H](C)[C@H](O)[C@]2(C)O)O[C@H](C)[C@@H]1O
9	P11387_DB05482	DB05482	7-ethyl-10-hydroxycamptothecin	n/a	IC50(nM) = 1000.0	FJHBVJOVLFPMQE-QFIPXVFZSA-N	CCC1=C2C=C(O)C=CC2=NC2=C1CN1C2=CC2=C(COC(=O)[C@]2(O)CC)C1=O
10	P11387_DB05630	DB05630	Sodium stibogluconate	inhibitor		YQDGWZZYGYKDLR-UZVLBLASSA-K	O.O.O.O.O.O.O.O.O.[Na+].[Na+].[Na+].[H][C@@]1(O[Sb]2(O)(O[Sb]34([O-])O[C@@H](C([O-])=O)[C@@]([H])(O3)[C@]([H])(O4)[C@H](O)CO)O[C@@H](C([O-])=O)[C@@]1([H])O2)[C@H](O)CO
11	P11387_DB05806	DB05806	Cositecan	n/a		POADTFBBIXOWFJ-VWLOTQADSA-N	CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C(CC[Si](C)(C)C)C4=CC=CC=C4N=C13)C2=O
12	P11387_DB06159	DB06159	Rubitecan	n/a		VHXNKPBCCMUMSW-FQEVSTJZSA-N	CC[C@@]1(O)C(=O)OCC2=C1C=C1N(CC3=C1N=C1C=CC=C(C1=C3)[N+]([O-])=O)C2=O
13	P11387_DB07354	DB07354	2,3-DIMETHOXY-12H-[1,3]DIOXOLO[5,6]INDENO[1,2-C]ISOQUINOLIN-6-IUM	n/a		LXDREMZQGAILJU-UHFFFAOYSA-O	COC1=C(OC)C=C2C3=C([NH+]=CC2=C1)C1=C(C3)C=C2OCOC2=C1
14	P11387_DB08159	DB08159	4-(5,11-DIOXO-5H-INDENO[1,2-C]ISOQUINOLIN-6(11H)-YL)BUTANOATE	n/a		AHIJTWCJGCWHMT-UHFFFAOYSA-N	OC(=O)CCCN1C2=C(C(=O)C3=CC=CC=C23)C2=CC=CC=C2C1=O
15	P11387_DB11254	DB11254	Hexylresorcinol	inhibitor		WFJIVOKAWHGMBH-UHFFFAOYSA-N	CCCCCCC1=C(O)C=C(O)C=C1